Citation Impact

8 standout
Sub-graph 1 of 4

Citing Papers

OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
2024 Standout
The landscape of nanoparticle-based siRNA delivery and therapeutic development
2024 Standout
1 intermediate paper

Works of Jonathan Weyne being referenced

Interim Analysis of an Open-Label, Ascending-Dose, Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of the Subcutaneously Administered Human Monoclonal Antibody Pozelimab in Combination with Single Doses of the Subcutaneously Administered siRNA Cemdisiran in Healthy Volunteers
2021
Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial
2020

Author Peers

Author Immunology Hematology Genetics Nephrology Last Decade Papers Cites
Jonathan Weyne 75 23 24 37 14 136
William C. Becker 1 1 29 747
Yoshinori Tamada 63 3 7 16 85 2.1k
Geir O. Gogstad 8 114 10 1 14 339
Andréia Alves Rezende 17 204
Salima Machkour‐M’Rabet 6 51 494

All Works

Loading papers...

Rankless by CCL
2026